Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0215762 TGF BETA RECEPTOR ANTAGONISTS
The invention relates generally to compounds that modulate the activity of TGF.beta.R-1 and TGF.beta.R-2, pharmaceutical compositions containing said compounds...
2018/0215761 TGF BETA RECEPTOR ANTAGONISTS
The invention relates generally to compounds that modulate the activity of TGF.beta.R-1 and TGF.beta. R-2, pharmaceutical compositions containing said...
2018/0215760 ARYL SUBSTITUTED BICYCLIC COMPOUNDS AS HERBICIDES
Disclosed are compounds of Formula 1, including all N-oxides, stereoisomers, and salts thereof, ##STR00001## wherein Q.sup.1, Q.sup.2, R.sup.1, R.sup.2, Y, J and...
2018/0215759 BICYCLIC INHIBITORS OF HISTONE DEACETYLASE
Provided herein are compounds and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of...
2018/0215758 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS
Bicyclic dihydropyrimidine-carboxamide compounds of formula I described herein inhibit Rho Kinase and may be used for the treatment of many disorders...
2018/0215757 COMPOUNDS AND METHODS FOR INHIBITING FASCIN
Provided are compounds, compositions and methods for inhibiting fascin activity or treating a condition or disorder mediated by fascin activity in a subject in...
2018/0215756 PROCESSES FOR PREPARING AN FGFR INHIBITOR
Disclosed herein are processes for preparing 8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxypheny- ...
2018/0215755 FACTOR XIA MACROCYCLIC INHIBITORS BEARING ALKYL OR CYCLOALKYL P2' MOIETIES
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables...
2018/0215754 1-SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,7-NAPHTHYRIDIN-8-AMINE DERIVATIVES AND THEIR USE AS EP4 RECEPTOR ANTAGONISTS
The present invention provides a compound represented by the formula (I): ##STR00001## wherein each symbol is as defined in the specification, or a salt thereof ...
2018/0215753 2-(1H-INDAZOL-3-YL)-1H-IMIDAZO[4,5-C]PYRIDINE AND THERAPEUTIC USES THEREOF
Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole...
2018/0215752 TETRAHYDRO-AZEPINOQUINOLINES AS AGONISTS OF THE 5-HT2C RECEPTOR
Certain tetrahydro-azepinoquinolines of structural formula I are agonists of the mammalian 5-HT.sub.2c receptor, and, in particular, are selective agonists of...
2018/0215751 5-METHYL-1,2,4-OXADIAZOL-3-YL COMPOUNDS
The present invention provides a compound of Formula I: ##STR00001## or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for...
2018/0215750 Novel Aminothiazole Compounds and Methods Using Same
The present invention includes novel aminothiazole compounds useful in preventing or treating cancer in a subject in need thereof. The present invention also...
2018/0215749 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE
Provided are compounds that are inhibitors of both rho kinase and of a monoamine transporter (MAT) act to improve the disease state or condition. Further...
2018/0215748 EPOTHILONE B AND DICTYOSTATIN ANALOGS, THEIR PREPARATION AND USE
A compound having the structure: ##STR00001##
2018/0215747 COMPOUND HAVING EP2 AGONIST ACTIVITY
Provided is an EP2 agonist having excellent safety. A compound represented by general formula (I) ##STR00001## (wherein all symbols are as defined in the...
2018/0215746 POTASSIUM CHANNEL MODULATORS
Provided are compounds and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated...
2018/0215745 KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
Certain compounds, or pharmaceutically acceptable salts or prodrugs thereof, are provided herein. Also provided are pharmaceutical compositions comprising at...
2018/0215744 SALTS OF QUINAZOLINE DERIVATIVE OR CRYSTALS THEREOF, AND THEPROCESS FOR PRODUCING THEREOF
Crystals of a quinazoline derivative are provided. The present invention relates to an acid addition salt of a compound represented by Formula (I): ...
2018/0215743 1,3,4-OXADIAZOLE AMIDE DERIVATIVE COMPOUND AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION...
The present invention relates to novel compounds having histone deacetylase 6 (HDAC6) inhibitory activity, stereoisomers thereof or pharmaceutically acceptable...
2018/0215742 PROTEASOME CHYMOTRYPSIN-LIKE INHIBITION USING PI-1833 ANALOGS
Focused library synthesis and medicinal chemistry on an oxadiazole-isopropylamide core proteasome inhibitor provided the lead compound that strongly inhibits...
2018/0215741 1-(Arylmethyl)quinazoline-2,4(1H,3H)-Diones as PARP Inhibitors and the Use Thereof
Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones represented by the Formula (I): ##STR00001## wherein Ar, R.sub.1-R.sub.6, are defined herein. Compounds...
2018/0215740 PARA-SUBSTITUTED INDANYL AND TETRALINYL DERIVATIVES
Compounds of formula I and formula II ##STR00001## their intermediates, as well as processes for the preparation of compounds of formula I and formula II, are...
2018/0215739 2-(1-HETEROARYLPIPERAZIN-4-YL)METHYL-1,4-BENZODIOXANE DERIVATIVES AS ALPHA2C ANTAGONISTS
Compounds of formula I, ##STR00001## wherein A is an optionally substituted five-membered unsaturated heterocyclic ring containing 1, 2, or 3 N, O, or S ring...
2018/0215737 SUBSTITUTED QUINAZOLINE COMPOUNDS AND PREPARATION AND USES THEREOF
The present invention relates quinazolinone compounds of Formula (I), as well as their preparation and uses, and further relates pharmaceutical compositions...
2018/0215736 BISAMIDINIUM-BASED INHIBITORS FOR THE TREATMENT OF MYOTONIC DYSTROPHY
The invention provides compounds, compositions and therapeutic methods. The compounds and compositions can be used for the treatment of myotonic dystrophy. The...
2018/0215735 METHOD FOR PREPARING METHYL (Z)-3-[[4-[METHYL[2-(4-METHYL-1-PIPERAZINYL)ACETYL]AMINO]PHEHYL]AMINO]PHE- ...
The invention relates to a method of synthesizing methyl (Z)-3-[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl] ...
2018/0215734 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS
The present invention provides kinase inhibitors with anti-proliferative activity comprising substituted pyrimidine derivatives and pharmaceutically-acceptable...
2018/0215733 POLYMORPHS OF SELINEXOR
The present invention relates to crystalline forms of the compound represented by Structural Formula I, and compositions comprising crystalline forms of the...
2018/0215732 BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS
The present invention is directed to benzoimidazole compounds of the formula: ##STR00001## and enantiomers, diastereomers, racemates, and pharmaceutically ...
2018/0215731 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME
The description relates to cereblon E3 ligase binding compounds, including bifunctional compounds comprising the same, which find utility as modulators of...
2018/0215730 AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS
Compound that is an inhibitor of at least one of the A.sub.2A and A.sub.2B adenosine receptors, and compositions containing the compound and methods for...
2018/0215729 NK 1 ANTAGONISTS
A compound having the general structure shown in Formula I: ##STR00001## or pharmaceutically acceptable salts and/or solvates thereof are useful in treating...
2018/0215728 Benzodiazepine Derivatives As CCK2/Gastrin Receptor Antagonists
The invention relates to benzodiazepine derivatives of formula (A) useful as CCK.sub.2/gastrin receptor antagonists, their preparation and their use in the...
2018/0215727 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF
Described herein are compounds that are LOXL2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such...
2018/0215726 CYCLOALKENYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS
The present invention provides compounds of formula (I): ##STR00001## or a pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein W, X, n, s, t,...
2018/0215725 PURIFYING CRUDE FURAN 2,5-DICARBOXYLIC ACID BY HYDROGENATION AND A PURGE ZONE
A process for purifying a crude furan 2,5-dicarboxylic acid composition (cFDCA) by hydrogenation of a FDCA composition dissolved in a hydrogenation solvent...
2018/0215724 PROCESS FOR PREPARING FURAN-2,5-DICARBOXYLIC ACID
A process for preparing furan-2,5-dicarboxylic acid is disclosed. The process includes the following steps: preparing or providing a starting mixture including...
2018/0215723 Substituted Hydrophobic Benzene Sulfonamide Thiazole Compounds for Use in Treating Cancer
The present invention relates to compound of general formula (I) R.sub.1 is selected from H, aryl and alkyl, R.sub.2 is selected from H, alkyl, aryl and...
2018/0215722 PROCESS FOR THE PREPARATION OF ISOCARBOXAZID
This invention relates to a novel chemical process for the synthesis of N'-benzyl-5-methylisoxazole-3-carbohydrazide (Isocarboxazid) which comprises reacting...
2018/0215721 TEAD TRANSCRIPTION FACTOR AUTOPALMITOYLATION INHIBITORS
The present disclosure compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the TEAD transcription factor, and...
2018/0215720 PYRIMIDINES AND USES THEREOF
The various examples presented herein are directed to compounds of the Formula: ##STR00001## wherein R.sup.1-R.sup.5 are defined herein, and uses of such...
2018/0215719 SIK INHIBITOR FOR USE IN A METHOD OF TREATING AN INFLAMMATORY AND/OR IMMUNE DISORDER
The present invention relates to the discovery that salt inducible kinases (SIKs) suppress the formation of anti-inflammatory molecules such as IL-10, which...
2018/0215718 PYRIDAZIN-3(2H)-ONE DERIVATIVES AS MONOAMINE OXIDASE SELECTIVE ISOFORM B INHIBITORS (As Amended)
The present invention refers to pyridazin-3(2H)-one derivatives of general structure I, II and III, which are selective MAO-B inhibitors, and to the use...
2018/0215717 FUSED IMIDAZOLES AS MIDH1 INHIBITORS
The present invention relates to compounds of general formula (I): in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10,...
2018/0215716 AROMATIC COMPOUND PRODUCTION METHOD
Provided is a method for producing an aromatic compound, which can produce a particular aromatic compound at high yield and can be industrially utilized....
2018/0215715 SOLID STATE FORMS OF NETARSUDIL MESYLATE
Disclosed are solid state forms of Netarsudil mesylate, processes for preparation thereof, uses thereof, and pharmaceutical compositions thereof.
2018/0215714 A Process for Preparing Indacaterol and Salts Thereof
The present invention relates to a process for preparing indacaterol or salts thereof. The process comprises of forming compound of Formula 1 by reacting...
2018/0215713 AMINOBENZAMIDE DERIVATIVES AS USEFUL AGENTS FOR CONTROLLING ANIMAL PARASITES
The invention relates to a composition comprising at least one aminobenzamide compound or a salt thereof for controlling animal parasites, veterinary...
2018/0215712 SMALL MOLECULE ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF
Small molecule carbazole compounds for use as androgen receptor inhibitors are provided herein. Also provided herein are methods for using the carbazole...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.